Literature DB >> 23530486

The findings of electrocardiography in patients with cardiac amyloidosis.

Zhongwei Cheng1, Kongbo Zhu, Zhuang Tian, Dachun Zhao, Quancai Cui, Quan Fang.   

Abstract

OBJECTIVE: The electrocardiography (ECG) was the simplest and common adjunctive diagnostic tool for cardiac amyloidosis (CA). We sought to clarify the findings of ECG in patients with CA in order to early identification of CA according to the findings of ECG.
METHODS: A total of 276 patients with diagnosis of systemic amyloidosis admitted to Peking Union Medical College Hospital from January 2000 to December 2011, were enrolled. Two groups were classified according to the cardiac involvement or not, namely CA (n = 189) and control (n = 87) groups. The low voltage on limb leads defined by the amplitude of the QRS complex in each limb leads ≤0.5 mV. The pseudo-infarct pattern defined by the presence of pathologic Q waves on at least two contiguous leads on ECG without obstructive coronary artery disease.
RESULTS: The mean age was 55 ± 12 (15-88) years, 168 patients (61%) were male. Atrial arrhythmia (15.9% vs 3.4%, P = 0.003), low voltage on limb leads (54.5% vs 20.7%, P < 0.001), atrioventricular block (14.8% vs 1.1%, P = 0.001) and pseudo-infarct pattern (40.2% vs 4.6%, P < 0.001) were more prevalent in CA than control groups. The combination of low voltage on limb leads and pseudo-infarct pattern was more common (28.0% vs 2.3%, P < 0.001) in CA than control groups. The sensitivity, specificity, positive and negative predictive values of the presence of low voltage on limb leads and pseudo-infarct pattern for the diagnosis of CA were 28%, 98%, 96%, and 39%, respectively.
CONCLUSION: In CA patients, low voltage on limb leads and pseudo-infarct pattern were the most common ECG findings. Atrial arrhythmia and atrioventricular block were the most common arrhythmias in CA patients. The combination of low voltage on limb leads and pseudo-infarct pattern had high specificity and positive predictive value for the diagnosis of CA. ©2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23530486      PMCID: PMC6932432          DOI: 10.1111/anec.12018

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  12 in total

1.  Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report.

Authors:  Julius M Gardin; David B Adams; Pamela S Douglas; Harvey Feigenbaum; David H Forst; Alan G Fraser; Paul A Grayburn; Alan S Katz; Andrew M Keller; Richard E Kerber; Bijoy K Khandheria; Allan L Klein; Roberto M Lang; Luc A Pierard; Miguel A Quinones; Ingela Schnittger
Journal:  J Am Soc Echocardiogr       Date:  2002-03       Impact factor: 5.251

2.  Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

Authors:  Blaithnead Murtagh; Stephen C Hammill; Morie A Gertz; Robert A Kyle; A Jamil Tajik; Martha Grogan
Journal:  Am J Cardiol       Date:  2005-02-15       Impact factor: 2.778

Review 3.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

Review 4.  Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Authors:  Morie A Gertz; Ray Comenzo; Rodney H Falk; Jean Paul Fermand; Bouke P Hazenberg; Philip N Hawkins; Giampaolo Merlini; Philippe Moreau; Pierre Ronco; Vaishali Sanchorawala; Orhan Sezer; Alan Solomon; Giles Grateau
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

5.  Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis.

Authors:  Zhongwei Cheng; Lin Kang; Zhuang Tian; Weiyun Chen; Wenjuan Guo; Jia Xu; Taibo Chen; Ligang Fang; Yong Zeng; Kang'an Cheng; Quan Fang
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

Review 6.  Amyloidosis and the heart: a comprehensive review.

Authors:  Keyur B Shah; Yoshio Inoue; Mandeep R Mehra
Journal:  Arch Intern Med       Date:  2006-09-25

7.  Current treatment in cardiac amyloidosis.

Authors:  Ivana Kholová; Josef Kautzner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

Review 8.  Evaluation and management of the cardiac amyloidosis.

Authors:  Joseph B Selvanayagam; Philip N Hawkins; Biju Paul; Saul G Myerson; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094

9.  Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis.

Authors:  Bethany A Austin; Brendan Duffy; Carmela Tan; E Rene Rodriguez; Randall C Starling; Milind Y Desai
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

10.  Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.

Authors:  Joseph E Rahman; Emelie F Helou; Ramona Gelzer-Bell; Richard E Thompson; Chih Kuo; E Rene Rodriguez; Joshua M Hare; Kenneth L Baughman; Edward K Kasper
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

View more
  9 in total

Review 1.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 2.  A systematic review and meta-analysis of the prevalence of transthyretin amyloidosis in heart failure with preserved ejection fraction.

Authors:  Mohamed Magdi; Mostafa Reda Mostafa; Waiel Abusnina; Ahmad Al-Abdouh; Ramy Doss; Sarah Mohamed; Chidera Philippa Ekpo; Richard Alweis; Bipul Baibhav
Journal:  Am J Cardiovasc Dis       Date:  2022-06-15

Review 3.  Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.

Authors:  Pablo Garcia-Pavia; Frank Bengel; Dulce Brito; Thibaud Damy; Franz Duca; Sharmila Dorbala; Jose Nativi-Nicolau; Laura Obici; Claudio Rapezzi; Yoshiki Sekijima; Perry M Elliott
Journal:  Eur J Heart Fail       Date:  2021-05-24       Impact factor: 17.349

4.  Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis.

Authors:  Lore Schrutka; Philip Anner; Asan Agibetov; Benjamin Seirer; Fabian Dusik; René Rettl; Franz Duca; Daniel Dalos; Theresa-Marie Dachs; Christina Binder; Roza Badr-Eslam; Johannes Kastner; Dietrich Beitzke; Christian Loewe; Christian Hengstenberg; Günther Laufer; Guenter Stix; Georg Dorffner; Diana Bonderman
Journal:  Heart       Date:  2022-06-24       Impact factor: 7.365

5.  Case report regarding the evolution of electrocardiographic and echocardiographic features in cardiac amyloidosis.

Authors:  Fabienne E Vervaat; Sjoerd Bouwmeester; Pieter-Jan Vlaar
Journal:  Eur Heart J Case Rep       Date:  2021-01-11

6.  AL type cardiac amyloidosis: a devastating fatal disease.

Authors:  Adeel Nasrullah; Anam Javed; Thejus T Jayakrishnan; Aaron Brumbaugh; Ariel Sandhu; Brent Hardman
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-05-10

7.  Cardiac Amyloidosis with Discordant QRS Voltage between Frontal and Precordial Leads.

Authors:  Csilla-Andrea Eötvös; Roxana-Daiana Lazar; Iulia-Georgiana Zehan; Erna-Brigitta Lévay-Hail; Giorgia Pastiu; Mihaela Pop; Anca Simona Bojan; Sorin Pop; Dan Blendea
Journal:  Medicina (Kaunas)       Date:  2021-06-27       Impact factor: 2.430

8.  Automated and Interpretable Patient ECG Profiles for Disease Detection, Tracking, and Discovery.

Authors:  Geoffrey H Tison; Jeffrey Zhang; Francesca N Delling; Rahul C Deo
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-09-05

9.  Cardiac Amyloidosis Detected on Imaging of Patients with Heart Failure.

Authors:  Siniša Roginić; Ozren Vinter; Matias Trbušić; Martina Roginić; Edina Ćatić Ćuti
Journal:  Am J Case Rep       Date:  2020-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.